Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T13:42:14.400Z.
Calculation as of: 2026-10-06T13:42:14.400Z.
Quote observation: 2026-10-06T13:38:54.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 26b9d76e1867df839f3ea79fd47ae1c5236575fa33f8c6240ddbf9d3395e1dfe
EARNINGS YIELD
N/A
Market Cap
$36.70M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.38M
Earnings Yield
N/A
TTM Avg
0.70%
3Y Avg
1.26%
5Y Avg
6.45%
Market Cap
$39.48M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.61M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $37.59M | N/A | 0.42% | 0.42% | 1.38% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.70M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.38M | N/A | 0.70% | 1.26% | 6.45% |
| Edesa Biotech, Inc. (EDSA)vs › | $38.53M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $37.40M | N/A | 6.97% | 4.38% | 4.29% |
| Elutia Inc (ELUT)vs › | $34.93M | 118.96% | 90.36% | 90.36% | 90.36% |
| Incannex Healthcare Limited (IXHL)vs › | $39.48M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.18M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
